ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO0384

Blood Pressure and Cardiovascular Events and Mortality in Maintenance Hemodialysis: A Nationwide Cohort Study

Session Information

Category: Dialysis

  • 801 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Jung, Hyejin, Department of Internal Medicine, Institute of Kidney Disease Research, Yonsei University College of Medicine, Seoul, Korea (the Republic of)
  • Park, Cheol Ho, Department of Internal Medicine, Institute of Kidney Disease Research, Yonsei University College of Medicine, Seoul, Korea (the Republic of)
  • Ko, Ye Eun, Department of Internal Medicine, Institute of Kidney Disease Research, Yonsei University College of Medicine, Seoul, Korea (the Republic of)
  • Ko, Byounghwi, Department of Internal Medicine, Institute of Kidney Disease Research, Yonsei University College of Medicine, Seoul, Korea (the Republic of)
  • Koh, Hee Byung, Department of Internal Medicine, Institute of Kidney Disease Research, Yonsei University College of Medicine, Seoul, Korea (the Republic of)
  • Park, Jung Tak, Department of Internal Medicine, Institute of Kidney Disease Research, Yonsei University College of Medicine, Seoul, Korea (the Republic of)
  • Han, Seung Hyeok, Department of Internal Medicine, Institute of Kidney Disease Research, Yonsei University College of Medicine, Seoul, Korea (the Republic of)
  • Yoo, Tae-Hyun, Department of Internal Medicine, Institute of Kidney Disease Research, Yonsei University College of Medicine, Seoul, Korea (the Republic of)
  • Kang, Shin-Wook, Department of Internal Medicine, Institute of Kidney Disease Research, Yonsei University College of Medicine, Seoul, Korea (the Republic of)
  • Kim, Hyung Woo, Department of Internal Medicine, Institute of Kidney Disease Research, Yonsei University College of Medicine, Seoul, Korea (the Republic of)
Background

Despite the high risk for cardiovascular event in ESKD patients, the optimal target blood pressure (BP) in these patients remains unclear. Therefore, this study aimed to investigate the association between blood pressure and adverse outcome in ESKD patients on maintenance hemodialysis.

Methods

A total of 40,065 patients receiving maintenance hemodialysis were included from the Periodic Hemodialysis Quality Assessment conducted by the Health Insurance Review and Assessment Service. Participants were categorized into 5 groups according to mean pre-dialysis SBP during the assessment period; <120, 120–129, 130–139, 140–149, and ≥150 mmHg. The primary outcome was a composite of nonfatal cardiovascular events (nonfatal myocardial infarction, coronary revascularization, nonfatal stroke, or hospitalization for heart failure) or all-cause mortality (major adverse cardiac and cerebrovascular events [MACCEs]).

Results

During a follow-up period of 230,750 person-years (median 6.1 years), MACCEs and all-cause death occurred in 26,268 patients (65.6%) and 23,049 patients (57.5%), respectively. Higher pre-dialysis SBP was associated with linearly higher incidence of MACCE (81.4, 99.9, 110.1, 116.2, and 131.3 events per 1000 person-years with increasing SBP categories). In the multivariable Cox proportional hazards model, the hazard ratios (95% confidence intervals) for MACCEs were 0.92 (0.86–0.99), 1.07 (1.03–1.12), 1.14 (1.09–1.19), and 1.27 (1.21–1.32) for the <120, 130–139, 140–149, and ≥150 mmHg SBP groups, respectively, compared with the reference group of 120–129 mmHg. When SBP was treated as a continuous variable, each 10mmHg increase was associated with a 1.07-fold higher risk of MACCE. Subgroup analysis revealed a significant interaction between SBP and interdialytic weight gain (IDWG, %), indicating that in patients with higher IDWG, the benefit of lowering SBP to below 120 mmHg was eliminated, while the risks associate with higher SBP was more pronounced.

Conclusion

In patients on maintenance hemodialysis, pre-dialysis SBP was linearly associated with the risk of MACCEs. However, the magnitude of risk varied according to the degree of IDWG, suggesting the need for individualized consideration of volume status when interpreting SBP targets in this population.

Digital Object Identifier (DOI)